CDK14 and triple-negative breast carcinoma: In triple-negative breast cancer, the CDK14/CCNY complex phosphorylates the membrane receptor LRP6 and regulates the activity of breast cancer stem cells through the Wnt/β-catenin signaling pathway, ultimately promoting the progression and metastasis of triple-negative breast cancer [15].